Recently, numerous metabolites possessing uncommon structures and potent bioactivity have been isolated from strains of fungi collected from diverse environments. The genus Aspergillus is known as a rich source of -butyrolactones. These are a group of fungal secondary metabolites, consisting of a fivemembered lactone bearing two aromatic rings, which shows a great variety of biological activities. This review summarizes the research on the biosynthesis, source, and biological activities of the naturally occurring -butyrolactones that have been isolated from Aspergillus species published over the last decades. More than 75 compounds are described and 65 references are cited.
Fungi have emerged as promising sources of microbial secondary metabolites [1] . They inhabit a wide range of environments, including extreme ones such as hyper-saline waters, tropical forests, and deserts. It has been reported that there are around 1.5 million different fungal species on earth, although only about 5% have been taxonomically described [2] . A wide variety of fungal-derived bioactive compounds have been described, including a number of antibacterial agents (e.g., cephalosporins), immunosuppressive drugs (e.g., cyclosporins), and anticancer candidates (e.g., plinabulin and fumagillin) [3] [4] . Aspergillus (family Aspergillaceae) is a large, diverse genus, containing about 180 filamentous fungal species of substantial pharmaceutical and commercial value [5] [6] [7] . Many compounds isolated from Aspergillus possess pharmacological and commercial value. Lovastatin (mevinolin), isolated from A. terreus, is one of the antihyperlipidemic drugs that inhibit cholesterol biosynthesis and was a major drug agent in the treatment of heart disease and atherosclerosis [8] [9] . Aspergillus is well known for the production of -butyrolactones, which are a class of amino acid derivative [1] . They are characterized by the presence of a basal skeleton of a fivemembered lactone bearing two aromatic rings [10] . Biogenetically, they are derived from oxidative deamination of amino acids, such as tyrosine and phenyl alanine [1, [11] [12] . -Butyrolactones have attracted much attention for their cytotoxic [13] [14] [15] [16] , anti-malarial [17] , anti-H1N1 [15] , anti-cholinesterase [18] , antimicrobial [1, [15] [16] 18] , and antioxidant [19] activities, and as lipooxygenase and cyclin-dependent kinase inhibitors [15, 19, [20] [21] [22] [23] . Furthermore, from the viewpoint of synthetic organic chemistry, the -butyrolactones are interesting targets to test novel synthetic strategies. A recent review of the available literature revealed that there are currently no reviews concerning the biosynthesis, isolation, and biological activities of naturally occurring -butyrolactones. In this review article, we focus on the -butyrolactones which have been isolated from Aspergillus species, their source, biosynthesis, and biological activities (Figures 1-7 , Table 1 ). This review, with more than 60 references, covers the literature from 1975 to 2016. A table containing compounds, sources from which they were isolated, their molecular weights, molecular formulae, and the references where they were described is included in this review ( Table 1) . The nomenclature and chemical structures are listed based on the literature. During our search we found that some of the published compounds have the same nomenclatures but different chemical structures, such as aspernolide D [24] [25] , aspernolide C [14, 25] , and aspulvinone H [26] [27] [28] . Also, some compounds have the same chemical structures and molecular formulae, but have different nomenclature e.g. butyrolactone VI (7) [29] and aspernolide D (20) [24] . The main aim of this review is to provide knowledge to researchers for rapid identification of -butyrolactones isolated from Aspergillus species. The highlight on bioactivity may possibly draw the attention of synthetic chemists for designing new drugs using known -butyrolactones as raw materials.
Biosynthesis of butyrolactone derivatives
The biosynthesis of the butyrolactone derivatives includes aldol condensation of two p-hydroxyphenylpyruvic acid (HPPA) methyl ester units, followed by ester cyclization to yield butyrolactone II (2) [30] . Also, butyrolactone II (2) could be produced through methylation of butyrolactone IV (5) in the presence of S-adenosylmethionine (SAM) [12, 24, 31] . The prenylation of butyrolactone II (2) in the presence of dimethylallylpyrophosphate (DMAPP) and subsequent epoxidation lead to the formation of butyrolactone I (1) and butyrolactone III (3), respectively [12, 24] . Furthermore, epoxide hydrolysis of butyrolactone III (3) forms butyrolactone VI (7) . Another biosynthetic pathway includes decarboxylation of butyrolactone IV (5), followed by C-4 hydroxylation to form 2-hydroxy-5-(4-hydroxybenzyl)-4-(4-hydroxyphenyl) furan-2(5H)-one (47) and 4-O-demethylisobutyrolactone II (13), respectively. The methylation of 4-O-demethylisobutyrolactone II (13) in the presence of SAM forms isobutyrolactone II (12) . The enzymecatalyzed cyclization or addition of water across the double bond of the prenyl chain of butyrolactone I (1) results in the formation of aspernolides A (16) and B (17), respectively [14] (Figure 1 ).
Pulvinones have been biosynthesized from either phenylalanine or phenyl pyruvate (arylpyruvates) via terphenyl benzoquinone [32] [33] [34] . The enol form of either PPA or HPPA has been formed. It undergoes head to tail condensation, followed by keto-enol tautermerization and a nucleophilic attack on the carbonyl carbon to yield the furanone partial structure. A spontaneous oxidation at the β-carbon occurs. Then, hydrolysis is followed by spontaneous decarboxylation, dehydroxylation, and keto-enol tautermerization to give the pulvinone core [35] (Figure 2 ). Aspulvinones have been biosynthesized from pulvinones by isoprenylation [32] .
Anti-diabetic activities: Compound 1 was evaluated for its α-glucosidase and α-amylase inhibitory activities. The results showed that 1 demonstrated significant inhibitory activity towards yeast α-glucosidase with an IC 50 of 52.2 μM compared with quercetin as a positive control with an IC 50 of 14.6 μM. However, it exhibited less activity towards rat intestinal α-glucosidase and α-amylase. The inhibitory activity could be attributed to the binding of 1 to a site other than the active site of the enzyme and combines with either free enzyme or the enzyme substrate complex, possibly interfering with the actions of both [58] . Haroon et al. reported that compound 50 showed considerable β-glucuronidase inhibitory activity with an IC 50 value of 6.2 µM [37] . Compound 1 exhibited moderate inhibitory activity with an IC 50 value of 96.7 µM (glucosaccharo-(1,4)-lactone, positive control, IC 50 48.4 µM). Compounds 1 and 2 showed significant inhibitory activities towards α-glucosidase with IC 50 values of 52.2 and 96.0 μM, respectively using quercetin as a positive control (IC 50 14.6 μM) [9] . Furthermore, compounds 1, 57, and 58 exhibited strong -glucosidase inhibitory activities with IC 50 values of 52.2, 2.7, and 8.9 µM, respectively compared with quercetin (positive control, IC 50 10.9 µM) [41] . Dewi et al. stated that compound 1 had a potent -glucosidase inhibitor with an IC 50 of 52.2 µM [59] . In contrast, compound 2, which lacks a prenyl side chain, exhibited less inhibitory activity (IC 50 96.0 µM). However, 16 produced a significant decrease in the inhibitory activity with an IC 50 of 175.2 µM compared with quercetin (positive control, IC 50 10.9 µM). Moreover, compounds 76 and 77 had glucose-6-phosphate translocase inhibitor activities with IC 50 values of 0.08 and 0.13 µM, respectively [56] . However, 57 showed only slight inhibitory activity with an IC 50 value of 200 µM in a microsomal glucose-6-phosphate activity assay [56] . It is noteworthy that 4, 71, and 72 showed stronger inhibitory activity on α-glucosidase with IC 50 values of 0.016, 0.079, and 0.022 M than acarbose (IC 50 0.685 M) [46] . Protein kinase inhibitory activities: Compound 1 was evaluated for its inhibitory effects on the expression of cyclins D2, A, and B1 in three human prostatic cancer cell lines (DU145, PC-3, and LNCaP) using two colored flow cytometric analysis. It selectively inhibited cyclin-dependent kinase B1. However, other cyclins were not significantly changed by 1. It caused an inhibition of cell [29] A. terreus isolated from the soft coral Sinularia kavarattiensis.
[14] A. terreus BCC 4651 isolated from a tree hole in Nam Nao National Park, Phetchabun Province, Thailand.
[17] A. terreus RCBC1002 isolated from the leaves of Mammea siamensis collected from Rayong.
[24] A. terreus A8-4 isolated from mangrove-associated marine sediments collected in Guangxi Zhuang Autonomous region of China.
[36]
A. terreus DRCC152, a mutant developed from ACCT20542.
[11] Aspergillus sp. (strain 05545) isolated from a marine sponge collected in 2005 in La Cruz, Costa Rica.
[26] Terrestrial A. flavipes MM2 isolated from rice hulls.
[28] A. terreus MXH-23 isolated from a sponge (unidentified) collected from Naozhou Sea, Guangdong Province, China.
[30]
A. terreus Thorn. var terreus isolated from a sample gathered in agricultural soils near to San Luis, Riobamba, Ecuador.
[18]
A. terreus isolated from the blades of the seaweed, Laurencia ceylanica, collected at Arugam Bay on the East coast of Sri Lanka.
[37]
A. fischeri TISTR 3272 obtained from the Thailand Institute of Scientific and Technological Research.
[38] Aspergillus sp. F1, a commensal fungal strain of Trewia nudiflora.
[39] A. terreus PT06-2 isolated from sediment (saline 20%), Putian Saltern of Fujian Province of China.
[15] A. terreus isolated from South China Sea (18° 11` N, 109° 25`E) gorgonian coral, Echinogorgia aurantiaca.
[10] A. versicolor isolated from the rhizome of Paris polyphylla var. yunnanensis.
[40] A. terreus LS07 isolated from sea shore in Teluk Kodek, Pamenang area, West Nusa, Tenggara Province, Indonesia.
[ 9 ]
Aspergillus sp. isolated from the sponge Cliona chilensis collected in the Pacific Ocean, Los Molles (IV Región, Chile).
[ 16] A. terreus RCC1, a mutant developed from ATCC 20542, obtained from the Research Center for Chemistry, Indonesian Institute of Sciences (RCC-LIPI), Indonesia.
[41]
A. terreus (HKI0499), was isolated from a soil sample.
[13] A. versicolor isolated from the rhizome of P. polyphylla var. yunnanensis, collected from Dali, Yunnan, Peopleʼs Republic of China.
[42]
A. terreus collected from 'paramo de Guasca' (Cundinamarca, Colombia).
[43] A. terreus isolated from the rhizome of P. polyphylla var. yunnanensis, collected from Dali, Yunnan, People's Republic of China.
[ 44] A. terreus isolated from desert soil.
[45] Butyrolactone II (2) A. terreus isolated from sediment collected from the lake of Wadi EI Natrun in Egypt.
[29] A. terreus BCC 4651 isolated from a tree hole in Nam Nao National Park, Phetchabun Province, Thailand.
[17] A. terreus RCBC1002 isolated from the leaves of M. siamensis collected from Rayong province, Thailand.
[24] A. terreus DRCC152, a mutant developed from ACCT20542.
[11] A. terreus MXH-23 isolated from a sponge (unidentified) collected from Naozhou Sea, Guangdong Province, China.
Aspergillus sp. F1, a commensal fungal strain of Trewia nudiflora.
[39] A. terreus PT06-2 isolated from sediment (saline 20%), Putian Saltern, Fujian Province of China.
[15] A. terreus LS07 isolated from the sea shore in Teluk Kodek, Pamenang area, West Nusa, Tenggara Province, Indonesia.
A. versicolor isolated from the rhizome of P. polyphylla var. yunnanensis, collected from Dali, Yunnan, Peopleʼs Republic of China.
Butyrolactone III (3)
A. terreus isolated from sediment collected from the lake of Wadi EI Natrun in Egypt. C 24 H 2 4O 8 440 [29] A. terreus RCBC1002 isolated from the leaves of M. siamensis collected from Rayong province, Thailand.
[24] A. terreus MXH-23 isolated from a sponge (unidentified) collected from Naozhou Sea, Guangdong Province, China.
A. terreus PT06-2 isolated from sediment (saline 20%), Putian Saltern of Fujian Province of China.
[15] A. terreus isolated from the South China Sea (18° 11′ N, 109° 25′ E) gorgonian coral Echinogorgia aurantiaca.
[10] A. terreus isolated from the rhizome of P. polyphylla var. yunnanensis, collected from Dali, Yunnan, People's Republic of China. [44] Methylbutyrolactone III (4) Aspergillus flavipes PJ03-11 isolated from wetland mud collected from Panjin Red Beach National Nature Reserve in Liaoning Province, China. Panjin Red Beach National Nature Reserve is located in the northeast of Bohai Bay and in the Liaohe River Delta wetland. [24] A. terreus DRCC152, a mutant developed from ACCT20542.
[28] A. terreus isolated from the South China Sea (18° 11′ N, 109° 25′ E) gorgonian coral Echinogorgia aurantiaca.
[10] A. versicolor isolated from the rhizome of P. polyphylla var. yunnanensis, collected from Dali, Yunnan, Peopleʼs Republic of China. [42] Butyrolactone V (6) A. terreus BCC 4651 isolated from a tree hole in Nam Nao National Park, Phetchabun Province, Thailand. [28] Aspergillus sp. F1, a commensal fungal strain of Trewia nudiflora.
[39] A. terreus isolated from the South China Sea (18° 11′ N, 109° 25′ E) gorgonian coral Echinogorgia aurantiaca.
[10] A. versicolor isolated from the rhizome of P. polyphylla var. yunnanensis, collected from Dali, Yunnan, Peopleʼs Republic of China. [42] Butyrolactone VI (7) A. terreus isolated from sediment collected from the lake of Wadi EI Natrun in Egypt. C 24 H 26 O 9 458
[29] A. terreus isolated from the roots of Carthamus lanatus, Egypt.
[ 6 ] A. terreus BCC 4651 isolated from a tree hole in Nam Nao National Park, Phetchabun Province, Thailand.
[17] Aspergillus sp. isolated from the sponge Cliona chilensis collected in the Pacific Ocean, Los Molles (IV Región, Chile) [16] Butyrolactone VII (8) A. terreus BCC 4651 was isolated from a tree hole in Nam Nao National Park, Phetchabun Province, Thailand. [ 29] 794 Natural Product Communications Vol. 12 (5) 2017 Ibrahim et al.
4-O-Demethylisobutyrolactone II (13)
A. terreus isolated from sediment collected from the lake of Wadi EI Natrun in Egypt. A. terreus PT06-2 isolated from sediment (saline 20%), Putian Saltern of Fujian.
[10] A. versicolor isolated from the rhizome of P. polyphylla var. yunnanensis, collected from Dali, Yunnan, People's Republic of China.
[25]
A. terreus isolated from the rhizome of P. polyphylla var. yunnanensis, collected from Dali, Yunnan, People's Republic of China. [44] Aspernolide B (17) A. terreus isolated from the soft coral Sinularia kavarattiensis.
A. terreus BCC 4651 isolated from a tree hole in Nam Nao National Park, Phetchabun Province, Thailand.
[17] A. terreus RCBC1002 isolated from the leaves of M. siamensis collected from Rayong.
[24] A. terreus isolated from the South China Sea (18° 11′ N, 109° 25′ E) gorgonian coral Echinogorgia aurantiaca.
[10] A. versicolor isolated from the rhizome of P. polyphylla var. yunnanensis.
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proliferation and incomplete cell cycle arrest in G2/M which allowed for occasional skipping of mitosis and subsequent progression through the cell cycle to occur [60] . Haritakun et al. reported that compound 1 had a specific eukalyotic cyclin-dependent kinases inhibitory activity [17] . Also, it showed high selectivity towards CDK1 and CDK2 [15] . Compounds 1, 10, and 11 were evaluated for their inhibitory activities on CDK1 (cyclin-dependent kinase 1/cyclin B; native, starfish oocytes), CDK5 (cyclin-dependent kinase 5/p25; recombinant, human), DYRK1A (dual-serine/threonine-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A; human, recombinant), CK1 (casein kinase 1; pig brain, native), and GSK-3/β (glycogen synthase kinase 3; pig brain, native). DYRK1A, CK1, and GSK-3 were insensitive to the tested compounds.
Compound 10 exhibited specific inhibitory activity against CDK1/cyclin B and CDK5/p25, 15-30-fold less than 1. However, 11 was inactive in all assays. The results indicated that the substitution of the hydroxy group at the alkenyl-substituted phenolic ring of 1 with a sulfate group rendered it inactive against CDK5 and CDK1. However, the presence of a sulfate group at the lactone moiety did not hinder CDK1 and CDK5 inhibition of 1 [13] .
Antiviral activities:
The antiviral activities of compounds 52, 57, and 58 were evaluated by the CPE inhibition (cytopathic effect inhibition) assay and MTT methods against influenza A H1N1 virus. They showed significant anti-influenza A virus activities with IC 50 values of 29.1, 56.9, and 32.3 µg/mL, respectively compared with ribavirin (positive control, IC 50 = 24.6 µg/mL) and Zanamivir (positive control, IC 50 = 28.4 ng/mL). They were also tested for their neuraminidase (NA) inhibitory activities using a neuraminidase inhibition assay Interestingly, 57 was only able to inhibit over 60% of NA activity at a concentration of 100 µg/mL compared with zanamivir (IC 50 8.1 ng/mL). Furthermore, 58 inhibited NA in inactivated viral suspensions of influenza A/PR/8/34 (H1N1) with an IC 50 value of 62.1 µg/mL [52] . However, 37 had no activity. Furthermore, 2 and 16 had antiviral activities towards HSV-1 with IC 50 values of 21.8 and 28.9 μg/mL, respectively compared with acyclovir (positive control, IC 50 34 .5 μg/mL) using the plaque reduction assay [10] . Compounds 1, 17, 22, 32, 33, and 47 were tested for their anti-tobacco mosaic virus (anti-TMV) activities at the concentration of 20 μM using the halfleaf method. The results showed that 33 exhibited high anti-TMV activity with an inhibition rate of 46.7% compared with ningnanmycin (30.6 inhibition %). The other compounds also exhibited anti-TMV activities with inhibition rates in the range of 21.8-28.4% [40] . Also, the anti-TMV activities of 1, 3, 16, 35, 36 , and 74 were evaluated using the half-leaf method. It is noteworthy that 35 and 36 showed high anti-TMV activities with inhibition rates of 35.2 and 31.0 %, respectively. However, 3, 1, 16, and 74 showed modest anti-TMV activity with inhibition rates of 21.8, 20.8, 24.6, and 15.4 %, respectively compared with ningnanmycin (30.6 inhibition %) [44] . Zhou et al. reported that 19 and 21 exhibited moderate anti-TMV activities with IC 50 values of 64.2 and 88.6 μM, respectively compared with ningnanmycin (IC 50 52.4 μM) using the half-leaf method [25] . Also, 5 and 39 showed high anti-TMV activities with inhibition rates of 35.4 and 46.4%, which were even more potent than ningnanmycin (30.8%). Compounds 1, 6, 7, and 40-42 showed moderate anti-TMV activities with inhibition rates of 20.7, 23.5, 21.5, 22.6, 25.4, and 18.6 %, respectively using the half-leaf method [42] . The antiviral activity towards H1N1 virus of 73 and 74 was evaluated by the CPE inhibition assay. They exhibited anti-H1N1 activities with IC 50 values of 221.6 and 87.1 µM, respectively compared with ribavirin (IC 50 118.8 µM). It is noteworthy that 74 showed either comparable or superior anti-H1N1 activity to that of ribavirin [57] .
Antimicrobial activities: Bai et al. reported that 43 showed significant antibacterial activity towards Staphylococcus aureus and Bacillus subtilis with MIC (minimal inhibitory concentration) values of 8.0 and 0.25 μg/mL, respectively [1] . It also exhibited unique anti-biofilm activity, where it could penetrate the biofilm matrix and kill the living bacteria inside mature S. aureus biofilm in both CV (crystal violet) and (2, 3-bis [2-methyloxy-4-nitro-5-sulfophenyl]-2H-tetrazolium-5-carboxanilide) reduction assays. Compounds 1 and 57 showed weak inhibition of B. cereus with MICs of 64 mg/mL using the broth micro-dilution method [29] . Moreover, 1, 2, 5-7, and 17 were weakly active or inactive towards Mycobacterium tuberculosis H37Ra [17] [15] . Compounds 1 and 7 were active against Clavibacter michiganensis 807. The MIQ (minimal quantity that showed a transparent halo of growth inhibition) value of 7 was 50 μg using the disc diffusion method [16] . Compound 23 exhibited good antifungal activity towards C. neoformans (IC 50 Cytotoxicity activities: Cytotoxic activities of 1, 2, 5-7, and 17 were evaluated towards KB (oral epidermoid carcinoma), MCF-7 (breast cancer), NCI-H187 (small-cell lung cancer), and noncancerous Vero cells (African green monkey kidney fibroblasts) using the green fluorescent protein microplate assay (GFPMA). The results showed that 1, 2, 5-7, and 17 exhibited either very weak or no cytotoxicity compared with ellipticine as positive control using the resazurin microplate assay [17] . Furthermore, 14 showed weak activity towards HCT-8 (human colon cancer), Bel-7402 (human hepatoma cancer), BGC-823 (human gastric cancer), and A2780 (human epithelial carcinoma) cell lines (IC 50 >10 µM) using the MTT assay [36] . Compounds 1, 2, and 5 showed mild in vivo cytotoxic activities towards MCF-7/ADR (human breast cancer), U251 (human CNS cancer), SW620 (human colon cancer), H522 (human lung cancer), M14 (human melanoma), SKOV3 (human ovarian cancer), DU145 (human prostate cancer), and A498 (human renal cancer) using the SRB method (sulforhodamine B colorimetric assay) [11] . Additionally, 1 exhibited weak cytotoxicity towards HL-60 (Caucasian promyelocytic leukemia) with an IC 50 value of 57.5 µM compared with ribavirin (IC 50 100.8 µM) and etoposide (0.042 µM) using the MTT assay [15] . It is noteworthy that 1 and 7 showed significant inhibition of the growth of crown gall tumors on potato discs with inhibition 46% and 64%, respectively, suggesting in vivo antitumor activity for both compounds [16] .
Moreover, 1 displayed anti-proliferative activities toward L-929 (mouse fibroblasts) and K562 (human chronic myeloid leukemia) cell lines with GI 50 (the concentration needed to reduce the growth of treated cells to half that of untreated cells) values of 32.3 and20.2 µM, respectively. Also, it showed cytotoxicity toward HeLa (human cervix carcinoma) cells with a CC 50 Antioxidant activities: Compounds 1, 2, and 16 showed significant activities against 1,1-diphenyl-2-picrylhydrazyl (DPPH) free radicals with IC 50 values of 51.39, 17.64, and 47.55 μM, respectively using quercetin as a positive control (IC 50 39.63 μM) [9, 59] . Compounds 57 and 58 exhibited moderate antioxidant activity in the DPPH assay with IC 50 values of 114.9, and 167.8 µM, respectively [41] . Also, Dewi et al. reported that 1 exhibited scavenging effects on DPPH (IC 50 = 51.1 μM, quercetin = IC 50 39 .6 μM as positive control) and hydrogen peroxide (IC 50 = 141.4 μM, quercetin = IC 50 123.8 μM as positive control) radicals, as well as in the reducing power assay [58] . The antioxidative activities of 73 and 74 were evaluated against DPPH and ABTS (2,2`-azino-di(3-ethylbenzthiazoline-6-sulfonic acid). Compound 73 displayed weak DPPH and ABTS radical-scavenging activities with IC 50 values of 43.4 and 1.33 μM, respectively, whilst 74 was inactive (IC 50 ˃100 and 50 μM, respectively) compared with the IC 50 values of ascorbic acid against DPPH and ABTS radicals and trolox against ABTS radical 1.7, 2.85, and 2.04 μM, respectively. The results showed that the presence of the phenolic OH in the benzyl nucleus has a key role in the antioxidant effect of 73 against DPPH and ABTS radicals [57] . Furthermore, 25, 26, and 27 exhibited significant ABTS radical scavenging activities with IC 50 values of 134.6, 124.6, and 29.5 M, respectively, compared with trolox (IC 50 13.1 M) [48] .
Anti-protozoal activities:
The antimalarial activities of 1, 2, 5-7, and 17 were evaluated towards Plasmodium falciparum K1 (multidrug resistant strain) using the microculture radioisotope technique. Only 6 showed moderate activity with an IC 50 value of 7.9 µg/mL compared with dihydroartemisinin (positive control, IC 50 0.00119 µg/mL) [17] .
Antifouling activities: Compounds 6, 16, and 17 had potent antifouling activity at nontoxic concentrations (LC 50 /EC 50 values >100 μg/mL) with EC 50 values of 22.1, 7.4, and 16.1 μg/mL towards the barnacle Balanus amphitrite larvae, respectively [10] . Weed growth inhibitory activities: Weed growth inhibitory activity of 1 was determined at 2 µg/µL towards the monocotyledonous and dicotyledonous weeds, Echinochloa crusgalli and Mimosa pigra, respectively. The compound showed strong inhibition, especially on the root growth of both weeds [38] . [6] .
In conclusion, -butyrolactones form a group of fungal secondary metabolites that fulfill all the requirements of being lead compounds in their respective therapeutic category. They possess varied chemical compositions and a wide array of biological activities. In this review, 77 naturally occurring fungal -butyrolactones are listed, and their biosynthetic pathways and biological activities are discussed.
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